Coffee Against Obstipation in Intensive Care Treatment

November 14, 2011 updated by: Christoph Eisenbach, University Hospital Heidelberg
Coffee might stimulate bowel movement and thus overcome obstipation in intensive care unit (ICU) patients.

Study Overview

Status

Unknown

Conditions

Detailed Description

Critically ill patients requiring ventilator support frequently suffer from obstipation. We hypothesize that coffee, administered either orally or rectally, might stimulate bowel movement.

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Heidelberg, Germany, 69120
        • University Hospital of Heidelberg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • admission to the medical intensive care unit of the Dept. of Gastroenterology at the university hospital heidelberg
  • requires ventilator support for an anticipated more than 72 hours
  • age older than 18 years

Exclusion Criteria:

  • pregnancy
  • known allergy to coffee
  • mechanical ileus
  • presence of enterostoma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: standard of care
patients receive standard care
Experimental: Coffee orally
patients will receive standard of care plus coffee orally
patients will receive a cup of coffee at room temperature orally twice daily
Experimental: coffee rectally
patients receive standard of care plus coffee rectally
patients receive an enema of two cups of coffee at room temperature once daily
Other Names:
  • Coffee

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Bowel movement rate
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 5 weeks
participants will be followed for the duration of hospital stay, an expected average of 5 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
time on mechanical ventilation
Time Frame: participants will be followed for the duration of intensive care unit stay, an expected average of 3 weeks
participants will be followed for the duration of intensive care unit stay, an expected average of 3 weeks
time of stay on ICU
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 5 weeks
participants will be followed for the duration of hospital stay, an expected average of 5 weeks
lengths of hospitalisation
Time Frame: an average of 5 weeks of hospital stay is expected
an average of 5 weeks of hospital stay is expected
in hospital mortality
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 5 weeks
participants will be followed for the duration of hospital stay, an expected average of 5 weeks
long term mortality
Time Frame: 6 months following discharge
6 months following discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christoph Eisenbach, University of Heidelberg, Heidelberg, Germany

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2011

Primary Completion (Anticipated)

December 1, 2013

Study Completion (Anticipated)

June 1, 2014

Study Registration Dates

First Submitted

November 10, 2011

First Submitted That Met QC Criteria

November 14, 2011

First Posted (Estimate)

November 17, 2011

Study Record Updates

Last Update Posted (Estimate)

November 17, 2011

Last Update Submitted That Met QC Criteria

November 14, 2011

Last Verified

November 1, 2011

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • COFFEE

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obstipation

Clinical Trials on coffee

3
Subscribe